Incidental Mutation 'R8277:Kat2b'
ID 638042
Institutional Source Beutler Lab
Gene Symbol Kat2b
Ensembl Gene ENSMUSG00000000708
Gene Name K(lysine) acetyltransferase 2B
Synonyms A930006P13Rik, Pcaf
MMRRC Submission 067700-MU
Accession Numbers
Essential gene? Non essential (E-score: 0.000) question?
Stock # R8277 (G1)
Quality Score 225.009
Status Validated
Chromosome 17
Chromosomal Location 53873889-53979748 bp(+) (GRCm39)
Type of Mutation missense
DNA Base Change (assembly) T to A at 53948281 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change Aspartic acid to Glutamic Acid at position 350 (D350E)
Ref Sequence ENSEMBL: ENSMUSP00000000724 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000000724] [ENSMUST00000164390] [ENSMUST00000166525]
AlphaFold Q9JHD1
Predicted Effect probably benign
Transcript: ENSMUST00000000724
AA Change: D350E

PolyPhen 2 Score 0.012 (Sensitivity: 0.96; Specificity: 0.78)
SMART Domains Protein: ENSMUSP00000000724
Gene: ENSMUSG00000000708
AA Change: D350E

DomainStartEndE-ValueType
low complexity region 4 21 N/A INTRINSIC
low complexity region 32 55 N/A INTRINSIC
Pfam:PCAF_N 56 308 6.2e-114 PFAM
low complexity region 461 472 N/A INTRINSIC
Pfam:Acetyltransf_7 522 605 1.5e-11 PFAM
Pfam:Acetyltransf_1 530 604 3.2e-11 PFAM
low complexity region 643 659 N/A INTRINSIC
BROMO 702 810 1.08e-44 SMART
Predicted Effect probably benign
Transcript: ENSMUST00000164390
SMART Domains Protein: ENSMUSP00000127659
Gene: ENSMUSG00000000708

DomainStartEndE-ValueType
Pfam:PCAF_N 1 210 6e-122 PFAM
Predicted Effect probably benign
Transcript: ENSMUST00000166525
Coding Region Coverage
  • 1x: 100.0%
  • 3x: 99.9%
  • 10x: 99.6%
  • 20x: 98.7%
Validation Efficiency 100% (43/43)
MGI Phenotype FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] CBP and p300 are large nuclear proteins that bind to many sequence-specific factors involved in cell growth and/or differentiation, including c-jun and the adenoviral oncoprotein E1A. The protein encoded by this gene associates with p300/CBP. It has in vitro and in vivo binding activity with CBP and p300, and competes with E1A for binding sites in p300/CBP. It has histone acetyl transferase activity with core histones and nucleosome core particles, indicating that this protein plays a direct role in transcriptional regulation. [provided by RefSeq, Jul 2008]
PHENOTYPE: Mice homozygous for a null allele exhibit no abrnomal phenotype. [provided by MGI curators]
Allele List at MGI

All alleles(122) : Targeted, knock-out(2) Targeted, other(1) Gene trapped(119)

Other mutations in this stock
Total: 42 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
Ablim1 C A 19: 57,204,351 (GRCm39) L13F probably benign Het
Apoe C T 7: 19,432,303 (GRCm39) probably benign Het
Arap2 A G 5: 62,771,335 (GRCm39) probably null Het
Aspm T C 1: 139,382,748 (GRCm39) S27P probably damaging Het
Atcay C A 10: 81,050,646 (GRCm39) D90Y probably damaging Het
Cd46 A T 1: 194,747,030 (GRCm39) D327E probably damaging Het
Cfh A G 1: 140,029,347 (GRCm39) W1001R probably damaging Het
Chrm2 G A 6: 36,500,211 (GRCm39) V23M probably benign Het
Col1a2 G A 6: 4,516,410 (GRCm39) G175R probably null Het
Ddx52 T C 11: 83,845,940 (GRCm39) S422P probably damaging Het
Dync2i2 A G 2: 29,923,886 (GRCm39) V213A probably benign Het
Entr1 G A 2: 26,274,778 (GRCm39) A373V probably damaging Het
Gucy2d T A 7: 98,092,682 (GRCm39) W20R probably benign Het
Hao2 A G 3: 98,787,700 (GRCm39) I243T probably damaging Het
Hmcn2 A C 2: 31,259,189 (GRCm39) T1010P probably benign Het
Iqcf1 T C 9: 106,379,077 (GRCm39) S29P probably benign Het
Lingo4 A G 3: 94,309,931 (GRCm39) S290G possibly damaging Het
Mmrn1 A G 6: 60,954,220 (GRCm39) T834A probably benign Het
Mro A T 18: 73,997,132 (GRCm39) probably benign Het
Mrps26 T A 2: 130,406,347 (GRCm39) L160Q probably damaging Het
Myh8 T C 11: 67,183,735 (GRCm39) I788T probably benign Het
Nab2 G A 10: 127,501,168 (GRCm39) probably benign Het
Nr2c2ap C T 8: 70,585,131 (GRCm39) Q67* probably null Het
Or1p1b C T 11: 74,130,842 (GRCm39) L151F probably benign Het
Pask C T 1: 93,253,085 (GRCm39) probably null Het
Pcnx2 A T 8: 126,592,755 (GRCm39) S736R probably damaging Het
Per2 G T 1: 91,348,274 (GRCm39) D1109E probably benign Het
Plxna1 G A 6: 89,334,162 (GRCm39) H156Y probably damaging Het
Polr2a G A 11: 69,638,882 (GRCm39) R51C probably damaging Het
Rbpms2 T A 9: 65,556,695 (GRCm39) F45Y probably damaging Het
Rmdn3 T C 2: 118,976,905 (GRCm39) D276G probably damaging Het
Septin2 T A 1: 93,427,030 (GRCm39) I171K probably benign Het
Serpinb3a C A 1: 106,973,970 (GRCm39) G314C probably damaging Het
Slc35f3 T A 8: 127,115,925 (GRCm39) V284D possibly damaging Het
Snapc4 A G 2: 26,255,722 (GRCm39) V934A probably benign Het
Tctn1 A G 5: 122,402,431 (GRCm39) M1T probably null Het
Tgoln1 G A 6: 72,593,838 (GRCm39) probably benign Het
Unc5c G A 3: 141,474,373 (GRCm39) probably null Het
Vmn2r11 A T 5: 109,202,833 (GRCm39) F81L probably benign Het
Vmn2r15 A T 5: 109,440,970 (GRCm39) V296E probably benign Het
Vmn2r15 C T 5: 109,441,310 (GRCm39) D183N probably damaging Het
Zfp763 T C 17: 33,252,294 (GRCm39) probably benign Het
Other mutations in Kat2b
AlleleSourceChrCoordTypePredicted EffectPPH Score
IGL00473:Kat2b APN 17 53,970,651 (GRCm39) missense possibly damaging 0.46
IGL00793:Kat2b APN 17 53,972,852 (GRCm39) missense probably benign 0.00
IGL01628:Kat2b APN 17 53,917,925 (GRCm39) missense possibly damaging 0.89
IGL02494:Kat2b APN 17 53,960,233 (GRCm39) missense probably damaging 1.00
IGL03347:Kat2b APN 17 53,931,379 (GRCm39) critical splice acceptor site probably null
cakewalk UTSW 17 53,945,550 (GRCm39) missense probably damaging 1.00
fracking UTSW 17 53,931,450 (GRCm39) missense probably damaging 1.00
D605:Kat2b UTSW 17 53,936,358 (GRCm39) missense probably damaging 1.00
R0060:Kat2b UTSW 17 53,961,571 (GRCm39) missense probably damaging 1.00
R0225:Kat2b UTSW 17 53,948,238 (GRCm39) missense probably damaging 1.00
R0372:Kat2b UTSW 17 53,945,565 (GRCm39) missense possibly damaging 0.95
R0638:Kat2b UTSW 17 53,951,771 (GRCm39) splice site probably benign
R0639:Kat2b UTSW 17 53,874,566 (GRCm39) missense probably benign 0.38
R0780:Kat2b UTSW 17 53,874,476 (GRCm39) missense unknown
R1240:Kat2b UTSW 17 53,931,425 (GRCm39) missense probably benign 0.00
R2346:Kat2b UTSW 17 53,917,932 (GRCm39) missense probably benign 0.07
R3402:Kat2b UTSW 17 53,972,881 (GRCm39) missense probably damaging 1.00
R3776:Kat2b UTSW 17 53,874,609 (GRCm39) splice site probably null
R4009:Kat2b UTSW 17 53,951,769 (GRCm39) splice site probably null
R4011:Kat2b UTSW 17 53,951,769 (GRCm39) splice site probably null
R4543:Kat2b UTSW 17 53,960,168 (GRCm39) missense probably benign
R4598:Kat2b UTSW 17 53,977,826 (GRCm39) missense probably benign 0.02
R4785:Kat2b UTSW 17 53,960,231 (GRCm39) missense possibly damaging 0.81
R5079:Kat2b UTSW 17 53,970,666 (GRCm39) missense probably damaging 1.00
R5475:Kat2b UTSW 17 53,970,609 (GRCm39) missense probably damaging 1.00
R6993:Kat2b UTSW 17 53,945,550 (GRCm39) missense probably damaging 1.00
R7047:Kat2b UTSW 17 53,970,597 (GRCm39) missense probably benign 0.01
R7058:Kat2b UTSW 17 53,972,894 (GRCm39) missense probably benign 0.00
R7199:Kat2b UTSW 17 53,977,706 (GRCm39) missense probably damaging 1.00
R7276:Kat2b UTSW 17 53,931,450 (GRCm39) missense probably damaging 1.00
R7418:Kat2b UTSW 17 53,917,953 (GRCm39) missense possibly damaging 0.94
R7535:Kat2b UTSW 17 53,931,431 (GRCm39) missense probably damaging 1.00
R7561:Kat2b UTSW 17 53,948,286 (GRCm39) missense probably benign 0.22
R7723:Kat2b UTSW 17 53,945,415 (GRCm39) missense possibly damaging 0.62
R7976:Kat2b UTSW 17 53,955,835 (GRCm39) missense probably benign 0.00
R8250:Kat2b UTSW 17 53,970,564 (GRCm39) missense probably damaging 1.00
R8969:Kat2b UTSW 17 53,967,116 (GRCm39) nonsense probably null
R9136:Kat2b UTSW 17 53,936,364 (GRCm39) missense probably benign 0.00
R9281:Kat2b UTSW 17 53,931,425 (GRCm39) missense probably benign 0.00
Predicted Primers PCR Primer
(F):5'- CCGCAGATGCTGTGAGTTACTG -3'
(R):5'- CAGATACCAGACTTACAGGCTCTAG -3'

Sequencing Primer
(F):5'- CCTGAGGACATTGTATTGCAGTC -3'
(R):5'- CAGACTTACAGGCTCTAGACATC -3'
Posted On 2020-07-28